Clinical trial
Comparison of the Safety and Efficacy of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties. A 4 Week,Randomized, Double-blind, Comparative, Parallel-group Study.
NCT00788515 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Safety and Efficacy of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties. A 4 Week,Randomized, Double-blind, Comparative, Parallel-group Study.
- Lead sponsor
- Sanofi
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 30, 2008
- Completion date
- January 31, 2009
- Enrollment
- 33 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.